7. In induced pluripotent stem cells:
(a) Germ cells are transformed and passaged continuously in culture to maintain a state conducive to
future pluripotent cell formation,
(b) Oncogenes are added to embryonic stem cells to help them retain stemness for prolonged
cultures.,
(c) Somatic cells are continuously cultured to generate a cell line that is mutagenized to produce
pluripotent cells when required
(d) Somatic cells are transduced with viral vectors coding for transcription factors that induce a
pluripotent state in the recipient cells,
Article:
Introduction to Induced Pluripotent Stem Cells (iPSCs)
Induced pluripotent stem cells (iPSCs) are a groundbreaking discovery in stem cell biology, offering a means to generate pluripotent stem cells from somatic cells. These cells have the ability to differentiate into virtually any type of cell in the body, making them invaluable for research and potential therapeutic applications in regenerative medicine.
The generation of iPSCs involves reprogramming somatic cells, such as skin or blood cells, into a pluripotent state. This reprogramming is facilitated by the introduction of specific transcription factors, which play a critical role in inducing pluripotency in the cells. The process is often carried out using viral vectors to deliver these factors into the target cells.
In this article, we will explore how iPSCs are created and the role that viral vectors and transcription factors play in reprogramming somatic cells.
The Process of Generating Induced Pluripotent Stem Cells
Induced pluripotent stem cells are created through a process known as cellular reprogramming. Here’s how the process typically works:
-
Starting with Somatic Cells: The process begins with somatic cells, such as fibroblasts (skin cells), that have already differentiated into specialized cells.
-
Introduction of Transcription Factors: The key to reprogramming these somatic cells into pluripotent cells is the introduction of a set of specific transcription factors. These factors, often called the Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc), are introduced into the somatic cells through viral vectors. These factors are crucial for “reprogramming” the somatic cells back to a pluripotent state, where they can differentiate into any type of cell.
-
Transduction with Viral Vectors: Viral vectors, such as lentiviruses or retroviruses, are commonly used to deliver the transcription factors into the somatic cells. The viral vectors are engineered to carry the genes encoding for these transcription factors and integrate them into the cells’ genomes.
-
Culturing and Selection: Once the transcription factors are introduced, the somatic cells are cultured under specific conditions conducive to reprogramming. Over time, a small percentage of these cells will transition into pluripotent cells, which have the ability to proliferate indefinitely and differentiate into various cell types.
The Role of Transcription Factors in Reprogramming
The transcription factors that are introduced into the somatic cells play a pivotal role in reprogramming. These factors activate genes that are involved in maintaining pluripotency and self-renewal. For example, Oct4 and Sox2 are critical for the maintenance of pluripotency, while Klf4 helps in the reprogramming process by reactivating the pluripotency gene network. c-Myc is involved in cell cycle regulation and cell growth.
Together, these transcription factors work in synergy to override the specialized state of somatic cells and return them to a pluripotent state, similar to embryonic stem cells.
Why Are iPSCs Important?
The creation of iPSCs holds great promise for several reasons:
-
Personalized Medicine: iPSCs can be derived from a patient’s own cells, making them a potential tool for personalized therapies. They can be used to create patient-specific cell lines for drug testing, disease modeling, and even cell-based therapies without the ethical concerns associated with using embryonic stem cells.
-
Regenerative Medicine: iPSCs have the potential to differentiate into any type of cell, which makes them a valuable resource for regenerative medicine. Researchers are exploring ways to use iPSCs to regenerate damaged tissues or replace cells lost due to disease or injury.
-
Disease Modeling and Drug Development: iPSCs allow researchers to model human diseases in the lab and test new drugs for efficacy and safety. By reprogramming patient-specific somatic cells into iPSCs, scientists can study diseases at the cellular level and discover new therapeutic targets.
Answer to the Question: How Are iPSCs Created?
The process of generating induced pluripotent stem cells from somatic cells is a sophisticated and highly controlled procedure. The correct answer to the question:
“How are induced pluripotent stem cells created?” is:
(d) Somatic cells are transduced with viral vectors coding for transcription factors that induce a pluripotent state in the recipient cells.
This method, using viral vectors to deliver transcription factors into somatic cells, is the foundational technique for generating iPSCs.
Conclusion
Induced pluripotent stem cells (iPSCs) are a revolutionary advancement in stem cell biology. By introducing specific transcription factors into somatic cells via viral vectors, researchers can reprogram these cells to a pluripotent state, where they have the ability to differentiate into a wide variety of cell types. This technique has opened up exciting possibilities in regenerative medicine, disease modeling, and personalized therapies.
Understanding the process of generating iPSCs, particularly the role of transcription factors and viral vectors, is essential for harnessing the full potential of these versatile cells in research and medicine.



2 Comments
Vikram
April 22, 2025🦢
yogesh sharma
May 8, 2025Done sir